Gallbladder Cancer Treatment in India
India sees a high incidence of gallbladder cancer, particularly in the Gangetic plains, making it one of the most experienced countries for gallbladder cancer surgery. Tata Memorial and AIIMS perform complex hepatectomy with bile duct resection for this challenging malignancy.
Get a Free Treatment Plan in 48 Hours
Send your reports — our specialists will review and send a personalised treatment plan and cost estimate.
📋 Get Free ConsultationSigns & Symptoms of Gallbladder Cancer
- Abdominal pain, particularly in the upper right quadrant
- Nausea and vomiting
- Jaundice (yellow skin and eyes)
- Fever
- Bloating and lumps in the abdomen
Treatment Options Available in India
- Extended cholecystectomy with liver bed resection
- Major hepatectomy with bile duct resection
- Portal vein embolization (to increase liver remnant)
- Gemcitabine + Cisplatin chemotherapy
- Durvalumab + Gemcitabine/Cisplatin (1st line)
- FOLFOX chemotherapy (2nd line)
Why Treat Gallbladder Cancer in India?
India offers world-class cancer care at a fraction of Western costs, with no compromise on quality or outcomes.
| Cost Comparison | India | USA |
|---|---|---|
| Gallbladder Cancer Treatment (total) | $6,000–$18,000 | $50,000–$180,000 |
| Savings with India | 60–80% less than USA | |
Best Hospitals
- Tata Memorial Hospital, Mumbai
- AIIMS, New Delhi
- Apollo Hospitals, Chennai
- Medanta — The Medicity, Gurugram
- Fortis Memorial Research Institute, Gurugram
Key Facts
- India performs more gallbladder cancer surgeries than most countries combined
- R0 resection rates at India's top HPB centres: 65–75%
- Gemcitabine + Cisplatin in India costs $2,000–$4,000 per cycle vs $15,000+ in USA
- Laparoscopic cholecystectomy to open conversion for staging is standard practice
Frequently Asked Questions
Q: What is the prognosis for gallbladder cancer treated in India?
A: Stage I gallbladder cancer has 80%+ 5-year survival with simple cholecystectomy. Stage II achieves 50–65% with extended cholecystectomy. Stage III/IV has poor prognosis even with surgery, but chemotherapy + immunotherapy can extend survival significantly.